Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells

BACKGROUND: Tamoxifen (TAM) is the eminent first-line drug for endocrine therapy of hormone receptor positive premenopausal breast cancer and reduces the risk of recurrence by ∼50%. However, many patients developed TAM resistance and their diseases recurred. Our previous study on transcriptome profi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Technol Cancer Res Treat
Main Authors: Men, Xin, Su, Mengyang, Ma, Jun, Mou, Yueyang, Dai, Penggao, Chen, Chao, Cheng, Xi An
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2021
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7989118/
https://ncbi.nlm.nih.gov/pubmed/33745390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/15330338211004916
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker